A Study of Hospital-at-Home for People Receiving Tarlatamab
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT06957314
- Status
- Recruiting
Conditions
- Small Cell Lung Carcinoma
- Small-cell Lung Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Hospital-at-Home/HAH — OTHERAfter discharge, a SeniorCare community paramedic will provide a home visit to the participant's home or residence
Study Details
The purpose of this study is to find out whether a Hospital-at-Home (HaH) program is a more efficient way to monitor people's health after receiving tarlatamab than monitoring in the hospital (inpatient).
Key Dates
- Start date
- Apr 23, 2025
- Status verified
- Mar 2026
- Primary completion
- Apr 23, 2028
- Completion
- Apr 23, 2028
Study Design
- Enrollment
- 70 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- No Intervention: Control ArmParticipants randomized to the control group will receive tarlatamab administration as per usual care.
- Experimental: Hospital-at-Home/HAH Intervention ArmParticipants randomized to the intervention group will receive tarlatamab administration through the hospital-at-home care delivery model.
Primary Outcome Measure
Number of inpatient hospital days [ Time Frame: 14 days ]
Central Contacts
- Robert Daly, MD, MBA646-608-3789
- Michael Offin, MD646-608-3763
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) | Basking Ridge | New Jersey | 07920 | Robert Daly, MD, MBA 646-608-3789 |
| Memorial Sloan Kettering Monmouth (Limited Protocol Activities) | Middletown | New Jersey | 07748 | Robert Daly, MD, MBA 646-608-3789 |
| Memorial Sloan Kettering Bergen (Limited Protocol Activities) | Montvale | New Jersey | 07645 | Robert Daly, MD, MBA 646-608-3789 |
| Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) | Commack | New York | 11725 | Robert Daly, MD, MBA 646-608-3789 |
| Memorial Sloan Kettering Westchester (Limited Protocol Activities) | Harrison | New York | 10604 | Robert Daly, MD, MBA 646-608-3789 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activites) | New York | New York | 10065 | Robert Daly, MD, MBA 646-608-3789 |
| Memorial Sloan Kettering Nassau (Limited Protocol Activities) | Uniondale | New York | 11553 | Robert Daly, MD, MBA 646-608-3789 |
Find similar trials in Basking Ridge, NJ
By research site
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)· Basking Ridge, NJMemorial Sloan Kettering Monmouth (Limited Protocol Activities)· Middletown, NJMemorial Sloan Kettering Bergen (Limited Protocol Activities)· Montvale, NJMemorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities)· Commack, NYMemorial Sloan Kettering Westchester (Limited Protocol Activities)· Harrison, NYMemorial Sloan Kettering Cancer Center (All Protocol Activites)· New York, NY
Related Studies
- PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56PHASE1/PHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · New York, New York
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)PHASE1/PHASE2 · Recruiting · PMV Pharmaceuticals, Inc · Irvine, California
- A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the BrainPHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine CancersPHASE2 · Recruiting · Boehringer Ingelheim · Mobile, Alabama